What is a Botanical Drug?
A botanical drug is composed of either a single plant or a blend of multiple plants. According to the US FDA, the entire combination is regarded as the active pharmaceutical ingredient (API) for a botanical drug.
Developing herbal medicines with established safety and effectiveness into prescription botanical drugs in the US is an efficient drug development route, comparing to the process of isolating a single molecular from a plant.
about the
American Botanical Drug Association
Why We Exist?
The FDA's “Botanical Drug Development Guidance for Industry" paves the way for botanical products such as herbal medicines and cannabis-derived products to evolve into prescription drugs. Utilizing the FDA botanical drug IND process to develop herbal medicines with established safety and effectiveness is a streamlined approach to drug development ...
Our Focus
Modern herbal medicines are typically available in pill or capsule formats. These products have already shown their safety and effectiveness through extensive daily use by a significant population. Identifying herbal medicines with established safety and effectiveness that have the potential to be developed into prescription botanical drugs in the United States represents an efficient drug development pathway ...
Registration open
in
Jan 2023
LEADERSHIP
.jpg)
David Allen
President
.jpg)
Purdeep Gupta
SVP, R&D
Andre Boulet
SVP, Canada
Pai-Ping Fan
SVP, United Kingdom
Simon Tang
General Counsel
Goran Olsson
CFO
Francis Hadji-Minaglou
SVP, France
Mary Brown
SVP, China
Yong Huang
Managing Director
Botanical Drug Impact Fund
.jpg)
Chun-Su, Yuan
SVP, Scientific Affairs
Joerg Gruenwald
SVP, Germany
Tirunagari Sreedhar
VP, India Central
John Tobin
SVP, Global BD
Donal Brown
SVP, Manufacturing & Quality
Alex Semprini
SVP, New Zealand
Steve Coucil
SVP, Strategic Initatives
Botanical Drugs Impact Fund
The Botanical Drug Impact Fund (BDIF) serves as an industry fund designed as a collaborative platform for the advancement of research and development in the field of botanical medicines. Within this platform, both institutions and individuals have the opportunity to actively contribute to the progress of disease treatment using herbal medicines by making contributions to the fund. Contributors are also able to select specific products or areas of disease treatment that align with their interests.
How We Do It?
Numerous medicinal herbal formulations from various regions around the world have shown both efficacy and safety within their respective markets. These herbal formulations are typically available in the form of pills or capsules and hold great potential for botanical drug development. However, the drug development process is intricate and time-consuming, often requiring a breadth of expertise that small entities may lack.
The Botanical Drug Impact Fund serves as a collective platform aimed at fostering collaborative efforts in advancing the research and development of herbal medicines into prescription botanical drugs. This endeavor seeks to address the treatment of challenging medical conditions for which effective chemical drugs are currently lacking. Through BDIF, individual investors have the opportunity to participate in substantial drug development initiatives, contributing to the advancement of medical science.
